Medical co-morbidity risk factors and barriers to care for people with schizophrenia

被引:78
作者
Muir-Cochrane, E. [1 ]
机构
[1] Univ S Australia, Sch Nursing & Midwifery, Div Hlth Sci, Adelaide, SA 5000, Australia
关键词
medical co-morbidity; role of the mental health nurse; schizophrenia;
D O I
10.1111/j.1365-2850.2006.01002.x
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The management of risk is a fundamental component of the work of mental health nurses and is most commonly associated with aggressive violent and suicidal behaviours exhibited, by those suffering from mental illness. However, people with severe mental illness are increasingly at risk of experiencing a number of related and complex health problems that include obesity, diabetes and cardiovascular disease. This group also has much higher rates of morbidity and mortality than that of the general population resulting in high social, economic and individual costs. Some of the barriers to receiving prompt and appropriate physical health care include lack of recognition by health professionals and the difficulties faced by consumers of mental health services in negotiating the health care system. Establishment of comprehensive (addressing both physical and mental health issues) programmes of care can address this need and offer additional opportunities for closer and more collaborative nurse-patient relationships. This paper explores risk factors for medical co-morbidity for people living with schizophrenia and suggests strategies that can facilitate better health outcomes.
引用
收藏
页码:447 / 452
页数:6
相关论文
共 46 条
[1]   SCHIZOPHRENIA - A LIFE-SHORTENING DISEASE [J].
ALLEBECK, P .
SCHIZOPHRENIA BULLETIN, 1989, 15 (01) :81-89
[2]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[3]  
[Anonymous], 2001, Duty to care: physical illness in people with mental illness
[4]  
[Anonymous], 2005, Practice Diabetes International, DOI DOI 10.1002/(ISSN)1528-252X
[5]   Body weight gain after administration of antipsychotic drugs:: Correlation with leptin, insulin and reproductive hormones [J].
Baptista, T ;
Lacruz, A ;
de Mendoza, S ;
Guillén, JMM ;
Silvera, R ;
Angeles, F ;
Mendoza, MT ;
Hernández, L .
PHARMACOPSYCHIATRY, 2000, 33 (03) :81-88
[6]   Body weight gain induced by antipsychotic drugs: mechanisms and management [J].
Baptista, T .
ACTA PSYCHIATRICA SCANDINAVICA, 1999, 100 (01) :3-16
[7]  
BERNSTEIN JG, 1988, CLIN NEUROPHARMACOL, V11, pS194
[8]  
CALLAGHAN P, 2005, J PSYCHIAT MENTAL HL, V11, P476
[9]  
Connolly M., 2005, Adv. Psychiatr. Treat, V11, P125, DOI DOI 10.1192/APT.11.2.125
[10]   The rising prevalence of diabetes and impaired glucose tolerance - The Australian diabetes, obesity and lifestyle study [J].
Dunstan, DW ;
Zimmet, PZ ;
Welborn, TA ;
de Courten, MP ;
Cameron, AJ ;
Sicree, RA ;
Dwyer, T ;
Colagiuri, S ;
Jolley, D ;
Knuiman, M ;
Atkins, R ;
Shaw, JE .
DIABETES CARE, 2002, 25 (05) :829-834